Clinical trial · Interventional
Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma
Use of Risk Factors for Initiation Therapy With Beacopp or Escalated Beacopp and Interim Evaluation and Modification of Therapy Based on Scintigraphy Results.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
.This study is trying to address change of chemotherapy dosage according to individual patient response to initial cycles of chemotherapy in order to reduce cumulative dose of chemotherapy.The study includes patients with early unfavorable and advanced hodgkin lymphoma. Patients with low risk were started with standard beacopp and only high risk patients were started with escalated beacopp.Following 2 cycles of therapy the patients were reassessed.Based on scintigraphy results decision was made regarding further therapylative chemotherapy for early responders and maximize dose intensity for late responders.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Classical Hodgkin Lymphoma | Classic Hodgkin Lymphoma | CURATED_BROADER | 0.80 |
| Lymphocyte Depletion | — | UNRESOLVED | — |
| Lymphocyte Rich | — | UNRESOLVED | — |
| Mixed Cellularity | — | UNRESOLVED | — |
| Nodular Sclerosis | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| "interim gallium or PET/CT" | Procedure | — | UNRESOLVED |
| interim therapy scintigraphy study gallium scan or PET/CT | Procedure | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * stage I-IIA/B with adverse prognostic or III-IV disease * Age 18 and Over * Performance status ECOG 0-3 * Hematopoietic WBC at least 4000/mm3(unless documented bone marrow involvement) * Hepatic bilirubin no greater then 5 mg/dL * RENAL:Creatinine no greater than 2.0mg/dL * not pregnant or nursing * Fertile patients must use effective contraception * HIV negative * No other malignancy within the past 5 years Exclusion Criteria: \-
References
Publications (0)
Data not yet available